Search clinical trials for: PTI-6D2

Total 2848 results

Pain Therapeutics

Completed

Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Metastatic Melanoma

Israel
Pain Therapeutics

Completed

Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Metastatic Melanoma

Israel
National Taiwan University Hospital Hsin-Chu Branch

Not yet recruiting

Comparative Efficacy of Different Time Interval Between rTMS and Rehabilitation Program for Motor Recovery in Stroke Patients

Stroke

Taiwan
Elixir Medical Corporation
European Cardiovascular Research Center

Terminated

DESolve® X-Pand Global Post Market Registry (X-Pand)

Coronary Artery Stenosis

Germany, Netherlands
Universitätsklinikum Hamburg-Eppendorf

Recruiting

Nasotracheal Intubation in Critically Ill. (NaTra-P)

Critical Care | Tracheal Intubation Morbidity

Germany
Proteostasis Therapeutics, Inc.

Completed

Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis

Healthy Volunteer - Complete | Cystic Fibrosis - Complete

United States, Belgium, United Kingdom, France, Germany, Canada, Denmark, New Zealand, Australia
Proteostasis Therapeutics, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis

Cystic Fibrosis

United Kingdom
Pain Therapeutics
National Institute on Aging (NIA)

Completed

A Safety Study of PTI-125 in Healthy Volunteers

Alzheimer Disease | Alzheimer Disease, Early Onset

United States
Oregon Research Institute

Completed

Transitional Treatment of Adolescents in Family Therapy (Transitions)

Substance Abuse

United States
Proteostasis Therapeutics, Inc.

Completed

Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis

Cystic Fibrosis

United States
Cassava Sciences, Inc.

Enrolling by invitation

Open-label Extension for Phase 3 Clinical Trials of Simufilam

Alzheimer Disease

United States, Canada, Puerto Rico
Proteostasis Therapeutics, Inc.

Completed

Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis

Cystic Fibrosis

United States, Canada, France, Denmark, Germany
Martina Hansen's Hospital
Oslo University Hospital; South-Eastern Norway Regional Health Authority; Lovisenberg...

Not yet recruiting

Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy

Arthralgia | Osteoarthritis, Knee | Knee Pain Chronic
Centre Hospitalier Universitaire de Nice

Completed

Drug-Eluting Balloon Angioplasty for the Treatment of Hemodialysis Vascular Access Stenosis (DEBAVAS) (B3AV)

Dysfunction of Hemodialysis Vascular Access (Fistula and Graft)

France
Fundación Pública Andaluza para la gestión de la...

Completed

Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study

Primary Immune Thrombocytopenia

Spain
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.

Not yet recruiting

Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Characteristics of HHT120 in Healthy Subjects (HHT120)

Healthy

China
Pain Therapeutics
National Institute on Aging (NIA)

Completed

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Alzheimer Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults

HIV Infections

United States, Switzerland
Proteostasis Therapeutics, Inc.

Completed

Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy

Cystic Fibrosis

United Kingdom
National Institute of Allergy and Infectious Diseases...
IPPOX Foundation; EuroVacc Foundation; Global Solutions for Infectious Diseases

Withdrawn

Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults

HIV Infections
Centre Hospitalier Universitaire, Amiens

Completed

Influence of the Operative Day on the Average Duration of Stay in Primary Hip and Knee Replacements (JourOpDMS)

Arthroplasty | Length of Stay

France
Proteostasis Therapeutics, Inc.

Completed

Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis

Cystic Fibrosis | Healthy Volunteer

United States, Canada, Denmark, Germany, Sweden
Ratio Therapeutics, Inc.

Completed

Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer

Prostate Cancer

United States
Cassava Sciences, Inc.
National Institute on Aging (NIA)

Completed

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients (PTI-125)

Alzheimer Disease

United States, Canada
Charite University, Berlin, Germany

Completed

Impact of Real-time Angiographic Co-registered OCT on PCI Results - the OPTICO-integration II Study (Integration-II)

Ischaemic Heart Disease

Germany
Maatschap Cardiologie Zwolle
Abbott; Radboudumc Technology Center; Clinical Studies

Recruiting

Use of Physiology to Evaluate Procedural Result After PCI CTO (ULTRA-CTO)

Percutaneous Coronary Revascularisation | Complex Coronary Lesion

Netherlands
Cassava Sciences, Inc.
Premier Research Group plc

Active, not recruiting

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease (RETHINK-ALZ)

Alzheimer Disease

United States, Australia, Canada
Cassava Sciences, Inc.
Premier Research Group plc

Active, not recruiting

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease (REFOCUS-ALZ)

Alzheimer Disease

United States, Korea, Republic of, Canada, Puerto Rico
ZOLL Circulation, Inc., USA

Completed

COOL AMI EU Pilot Trial to Assess Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction

Acute Myocardial Infarction

Slovenia, Poland, Austria, Estonia, Hungary, Serbia, Sweden, United Kingdom
Duke University
Food and Drug Administration (FDA); Medtronic; Abbott Medical Devices; The Medicines... and other collaborators

Terminated

SAFE-PCI for Women (SAFE-PCI)

Percutaneous Coronary Intervention | Ischemic Symptoms
Ospedale San Donato

Unknown

Drug Eluting Balloon in peripherAl inTErvention for Below-The-Knee Arteries With Freeway and Lutonix

Peripheral Artery Disease

Italy
Pyramid Biosciences

Completed

A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers

Formulation Bridging and Food Effect in Healthy Volunteers

United States
Unity Health Toronto

Unknown

Revascularization Strategies for STEMI; The CMR Endpoint Study (ASSIST-CMR)

Acute Myocardial Infarction

Canada
Takeda
Intra-Cellular Therapies, Inc.

Terminated

Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia

Schizophrenia

United States
PTS International Inc.

Withdrawn

A Study of PTS for Patients With Solid Tumors

Solid Tumor

United States
General Hospital of Ningxia Medical University

Unknown

HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer

Carcinoma, Small Cell Lung

China
PreCision Dermatology, Inc.

Unknown

An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea

Rosacea

United States
Heinrich-Heine University, Duesseldorf
Philips Medical Systems

Unknown

PCI Suite: Road Map Fusion Imaging in Coronary Diagnostics and Therapy (PCI Suite)

Coronary Disease

Germany
Shanghai 10th People's Hospital
The First Affiliated Hospital with Nanjing Medical University

Unknown

Autologous Endothelial Progenitor Cells Treatment of Diabetic Foot

Diabetic Foot

China
Modulation Therapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma

Uveal Melanoma | Metastatic

United States
Göteborg University
Sahlgrenska University Hospital, Sweden

Withdrawn

Quality of Life and Target Achievement After Treatment of Patients With Stable Angina Pectoris (LOBSTR)

Stable Angina Pectoris

Sweden
Apceth GmbH & Co. KG

Completed

Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia

Peripheral Artery Disease | Critical Limb Ischemia

Germany
Pain Therapeutics

Completed

Long-term Safety of PF-00345439 (Oxycodone)

Pain
Shenzhen Raysight Intelligent Medical Technology...
Shanghai Zhongshan Hospital; West China Hospital; Shenzhen People's Hospital

Not yet recruiting

Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Vascular Disease Occlusive

China
CoreAalst BV

Recruiting

Precise Procedural and PCI Plan (P4) (P4)

Coronary Artery Disease

Denmark, United Kingdom, Belgium, Italy, Hungary
Micro Medical Solution, Inc.

Recruiting

A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)

Peripheral Arterial Disease

United States
Presidio Pharmaceuticals, Inc.

Completed

Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations

Pharmacokinetic Assessments in Healthy Volunteers

United States
Dartmouth-Hitchcock Medical Center
PSI Medical

Completed

Reduction in IV Associated Contamination

Post-operative Infections

United States
Aarhus University Hospital Skejby
Abbott

Active, not recruiting

The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) (OCTOBER)

Ischemic Heart Disease | Ischaemic Heart Disease

Denmark, United Kingdom, Sweden, Finland, Germany, Belgium, Norway, Poland, Netherlands, Estonia, Ireland, Italy, Latvia
Cassava Sciences, Inc.
Worldwide Clinical Trials

Completed

Food Effect and Bioequivalence Study of Simufilam Tablets in Healthy Volunteers

Healthy Volunteers

United States

Search clinical trials for: PTI-6D2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations